[Federal Register Volume 60, Number 114 (Wednesday, June 14, 1995)]
[Notices]
[Pages 31310-31311]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-14654]



=======================================================================
-----------------------------------------------------------------------

[[Page 31311]]


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committees; Ad Hoc Advisory Committee on Creutzfeldt-
Jakob Disease; Establishment

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
establishment by the Secretary of Health and Human Services (the 
Secretary), of the Ad Hoc Advisory Committee on Creutzfeldt-Jakob 
Disease.
DATES: Authorization for the Committee being established will end on 
June 9, 1996.

FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management 
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-443-2765.

SUPPLEMENTARY INFORMATION:  Under the Federal Advisory Committee Act of 
October 6, 1972, Pub. L. 92-463, as amended (5 U.S.C. app. 2), and 21 
CFR 14.40(b), FDA is announcing the establishment by the Secretary of 
the Ad Hoc Advisory Committee on Creutzfeldt-Jacob Disease.
    The Ad Hoc Advisory Committee on Creutzfeldt-Jakob Disease will 
review and evaluate available data concerning the safety of blood 
products obtained from, a donor who, after donation, was diagnosed with 
Creutzfeldt-Jakob Disease, and make recommendations regarding the 
disposition of such blood products to the Commissioner of Food and 
Drugs.

    Dated: June 12, 1995.
David A. Kessler,
Commissioner of Food and Drugs.
[FR Doc. 95-14654 Filed 6-12-95; 10:56 am]
BILLING CODE 4160-01-F